UnitedHealth Group Incorporated Website

UnitedHealth Group Incorporated

NYSE-UNH

Company Overview

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.

  • Name

    UnitedHealth Group Incorporated

  • CEO

    Stephen J. Hemsley

  • Website

    www.unitedhealthgroup.com

  • Sector

    Health Care Providers and Services

  • Year Founded

    1974

Company Statistics

Profile

  • Market Cap

    —

  • EV

    —

  • Shares Out

    —

  • Revenue

    —

  • Employees

    —

Margins

  • Gross

    —

  • EBITDA

    —

  • Operating

    —

  • Pre-Tax

    —

  • Net

    —

  • FCF

    —

Returns (5Yr Avg)

  • ROA

    —

  • ROTA

    —

  • ROE

    —

  • ROCE

    —

  • ROIC

    —

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    —

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    —

  • Net Debt

    —

  • Debt/Equity

    —

  • EBIT/Interest

    —

Growth (CAGR)

  • Rev 3Yr

    —

  • Rev 5Yr

    —

  • Rev 10Yr

    —

  • Dil EPS 3Yr

    —

  • Dil EPS 5Yr

    —

  • Dil EPS 10Yr

    —

  • Rev Fwd 2Yr

    —

  • EBITDA Fwd 2Yr

    —

  • EPS Fwd 2Yr

    —

  • EPS LT Growth Est

    —

Dividends

  • Yield

    —

  • Payout

    —

  • DPS

    —

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    —

Bulls Say

  • UnitedHealth's strategy of providing medical insurance, pharmacy benefits, and healthcare services should create a powerful alignment of incentives to help clients control their healthcare costs better than pure-play competitors.

  • As the leading provider of Medicare Advantage plans in the US, UnitedHealth should benefit from ongoing demographic shifts and the increasing popularity of these plans among seniors.

  • UnitedHealth has managed its balance sheet more conservatively than peers, which should give it more financial flexibility during uncertain periods like the current environment.

Bears Say

  • Regulatory scrutiny appears targeted specifically at UnitedHealth, with ongoing antitrust investigations, questions around its risk assessments in Medicare Advantage, and scrutiny of its coverage denial rates in focus.

  • The insurance and PBM industries will likely remain targets of regulators aiming to increase health coverage and reduce the healthcare cost burden on society until the US achieves universal, affordable coverage.

  • The law of large numbers may eventually catch up to this healthcare behemoth, making its 13%-16% earnings growth goal difficult to achieve in the long run.

Source: Morningstar Analysis - Nov 12, 2025

What's happening

Nov 8, 2025 - Dec 9, 2025

UnitedHealth Group Inc Faces Challenges Amid Strategic Shifts and Market Dynamics

  • UnitedHealth Group Inc announced the sale of Banmedica for $1 billion, following significant losses in South American operations.
  • The appointment of former FDA Commissioner Scott Gottlieb as a board member coincided with rising Medicare premium costs, raising concerns about future revenue.
  • Social media discussions reflected mixed sentiments regarding UNH's prospects amid ongoing healthcare reform debates.

Over the past month, UnitedHealth Group Inc (UNH) experienced a slight decline of 1.9%, underperforming relative to the S&P 500, which returned 2.2%. This performance reflects broader market dynamics and specific challenges faced by UNH amidst discussions surrounding healthcare reforms and fluctuating investor sentiment. A key event influencing UNH’s stock was its announcement regarding the divestment of Banmedica for $1 billion to Patria Investments after incurring substantial losses totaling $8.3 billion from South American operations.

Market perception during this period revealed a mix of bullish and bearish sentiments on social media platforms throughout November. Positive posts highlighted potential advancements related to health insurance subsidies tied to the Affordable Care Act (ACA). However, despite these optimistic views, there was an overall negative trend in price movement leading up to earnings reports that exceeded expectations but did not significantly boost stock prices.

The recent appointment of Scott Gottlieb as a board member attracted attention; however, it coincided with rising costs associated with Medicare premiums that could negatively impact future revenue streams for UNH amid increasing regulatory scrutiny over healthcare expenses. During this time frame, the company's stock reached a ten-week low due in part to concerns over operational strategies and external economic pressures affecting healthcare stocks broadly.

While there were moments reflecting optimism through social media engagement around potential recovery points for UNH's price levels—such as bouncing off key moving averages—the prevailing narrative remained cautious amid significant sell-offs and strategic shifts within the company itself. Ultimately, UnitedHealth Group Inc underperformed the Health Care (XLV) sector by -1.7%.

NYSE:UNH